We are live on ! Find out more
XGN icon

Exagen
XGN

54 hedge funds and large institutions have $129M invested in Exagen in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

3.77% less ownership

Funds ownership: 54.65% → 50.88% (-3.8%)

5% less funds holding

Funds holding: 57 → 54 (-3)

18% less capital invested

Capital invested by funds: $156M → $129M (-$27.4M)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

Holders
54
Holders Change
-3
Holders Change %
-5.26%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
26
Reduced
16
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.98M
2
Deutsche Bank
Deutsche Bank
Germany
+$4.64M
3
CAC
Cowen and Company
New York
+$4.21M
4
Morgan Stanley
Morgan Stanley
New York
+$4.08M
5
BCI
Brinker Capital Investments
Pennsylvania
+$1.84M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$12.3M
2
PVI
Pura Vida Investments
New York
-$4.29M
3
PGM
Parian Global Management
New York
-$3.37M
4
MIM
Monashee Investment Management
Massachusetts
-$3.01M
5
EP
Eversept Partners
New York
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$25.4M +$33.3K +2,171 +0.1%
RI
2
RTW Investments
New York
$12.3M -$12.3M -804,951 -49%
CAC
3
Cowen and Company
New York
$10.9M +$4.21M +274,257 +61%
BlackRock
4
BlackRock
New York
$8.78M +$4.98M +324,932 +125%
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.79M +$1.64M +106,908 +26%
PIM
6
Platinum Investment Management
Australia
$6M – – –
NCM
7
Nantahala Capital Management
Connecticut
$5.51M -$97.8K -6,379 -2%
Morgan Stanley
8
Morgan Stanley
New York
$5.47M +$4.08M +266,001 +269%
Nomura Holdings
9
Nomura Holdings
Japan
$5.33M – – –
SAM
10
Silvercrest Asset Management
New York
$4.65M -$19.3K -1,257 -0.4%
Deutsche Bank
11
Deutsche Bank
Germany
$4.58M +$4.64M +302,685 +9,834%
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$3.55M -$2.06K -134 -0.1%
SC
13
Samjo Capital
New York
$3.07M +$843K +55,000 +37%
PCM
14
Perkins Capital Management
Minnesota
$3M -$46.8K -3,050 -1%
SCM
15
Stonepine Capital Management
Oregon
$2.54M -$329K -21,464 -11%
MS
16
Maven Securities
Jersey
$2.47M -$170K -11,087 -6%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.08M +$856K +55,799 +67%
UBS Group
18
UBS Group
Switzerland
$1.94M -$51.2K -3,342 -3%
BCI
19
Brinker Capital Investments
Pennsylvania
$1.8M +$1.84M +120,239 New
Northern Trust
20
Northern Trust
Illinois
$1.46M +$671K +43,784 +82%
State Street
21
State Street
Massachusetts
$1.4M +$389K +25,341 +37%
BCM
22
Bridgeway Capital Management
Texas
$1.16M +$38.3K +2,500 +3%
Millennium Management
23
Millennium Management
New York
$1.14M +$1.17M +76,058 New
PVI
24
Pura Vida Investments
New York
$772K -$4.29M -279,639 -84%
Victory Capital Management
25
Victory Capital Management
Texas
$545K -$543K -35,427 -49%
1
2 3

XGN Hedge Fund Activity: Q2 2021 in Review

54 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2021, worth a combined $129M — down 18% from $156M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of XGN and 8 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $4.98M. The largest seller was RTW Investments, cutting an estimated $12.3M.

  • 54 institutional investors held Exagen (XGN) as of Q2 2021, down from 57 in Q1 2021.
  • Funds reported $129M of Exagen stock for Q2 2021, down 18% quarter-over-quarter.
  • 8 funds opened new Exagen positions in Q2 2021 and 11 closed out, a net change of -3 holders.
  • The largest Exagen buyer in Q2 2021 was BlackRock, an estimated $4.98M added.
  • The largest Exagen seller in Q2 2021 was RTW Investments, an estimated $12.3M sold.

Based on aggregated 13F filings for Q2 2021.